Zerit (stavudine) for Oral Solution

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- April 2008

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.

Summary View

Sections Modified

ADVERSE REACTIONS

• Observed During Clinical Practice
  • Metabolic Disorders
    • Diabetes Mellitus and Hyperglycemia

PATIENT PACKAGE INSERT

• What are the possible side effects of Zerit?
  • Other Side Effects
    • ...high blood sugar (hyperglycemia or diabetes)...